Learning Objectives:

1. Review the strengths and weaknesses of the recent BLISS-LN trial.

2. Discuss the applicability of the trial's findings.

3. Integrate these findings into our current understanding of lupus nephritis management.

Session date: 
Tuesday, October 20, 2020 - 8:30am to 9:30am
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Emily Peninger, M.D.